Any current/future new fundraising through debt or equity?

There is no explicit mention of any immediate or planned fundraising through debt or equity in the provided transcript. The promoters are focused on increasing their stake using arranged funds or assets, not specifically through fresh equity issuance. Management plans to use the significant funds expected from the DyStar sale (approx. Rs. 603.8 million) mostly for growth projects, new exciting sectors, and shareholder benefits. No mention of new debt is made; rather, emphasis is on utilizing existing resources and cash inflows. The company aims to invest in new projects with high IRR (minimum

Any current/future capex/capital investment/strategic investment?

No significant CAPEX needed to improve existing business; focus is on internal improvements within current investments (Page 23). Efforts ongoing to reduce power costs, improve efficiencies, restart certain buildings with new production, and explore new products using existing facilities (Page 23). Looking at future projects related to renewable energy, green hydrogen, electric vehicles, and petrochemical derivatives, but nothing has been finalized yet due to market dynamics (Page 23). Management targets new projects with minimum IRR of 25%, ideally aiming for over 30% IRR (Page 6). Majority o

Future growth expectations in sales/revenue/volumes?

For FY 2024-25, Kiri Industries expects consolidated revenue to cross Rs. 1200 crore. They aim to improve consolidated EBITDA from 3% to between 5% to 10%. Current focus is on increasing profitability by changing product mix within existing operations without requiring significant CAPEX. New projects under consideration include renewable energy, green hydrogen, electric vehicles, and petrochemical derivatives for future growth. Management is preparing groundwork for these new projects but will announce specifics once fund visibility improves. The sale of DyStar is expected to conclude by mid-2

Future growth expectations in earnings/operating earnings/profits/EPS?

For FY25, Kiri Industries expects consolidated revenue of around ₹1,200 crore. Consolidated EBITDA is targeted to improve from 3% in FY24 to between 5%-10% in FY25, reflecting operational improvements and demand revival. The standalone business showed a 27% revenue growth in Q4 FY24, with a significant reduction in EBITDA loss, indicating improving profitability trends. The company aims to turn positive cash flows by optimizing product mix and improving efficiencies. New projects in high-growth sectors like green hydrogen, renewable energy, electric vehicles, and petrochemical derivati

Kiri Industries LtdQ4 FY24Chemicals & Petrochemicals

Kiri Industries Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹521.6P/E: 4.2Market Cap: ₹3.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

For FY 2024-25, Kiri Industries expects consolidated revenue to cross Rs. 1200 crore.
They aim to improve consolidated EBITDA from 3% to between 5% to 10%.
Current focus is on increasing profitability by changing product mix within existing operations without requiring significant CAPEX.
New projects under consideration include renewable energy, green hydrogen, electric vehicles, and petrochemical derivatives for future growth.
Management is preparing groundwork for these new projects but will announce specifics once fund visibility improves.
The sale of DyStar is expected to conclude by mid-2025, which will provide cash to fund growth initiatives.
The targeted internal rate of return (IRR) for new capex projects is at least 25-30%.
Efforts continue on operational efficiency improvements and capacity utilization enhancement.

Margin guidance

Category 3

For FY25, Kiri Industries expects consolidated revenue of around ₹1,200 crore.
Consolidated EBITDA is targeted to improve from 3% in FY24 to between 5%-10% in FY25, reflecting operational improvements and demand revival.
The standalone business showed a 27% revenue growth in Q4 FY24, with a significant reduction in EBITDA loss, indicating improving profitability trends.
The company aims to turn positive cash flows by optimizing product mix and improving efficiencies.
New projects in high-growth sectors like green hydrogen, renewable energy, electric vehicles, and petrochemical derivatives are being explored to drive future growth with targeted IRRs of 25%-30%.
Majority of funds, including the upcoming DyStar litigation proceeds, will be deployed toward these growth initiatives rather than shareholder returns.
Legal expenses have impacted earnings in the past, but litigation is nearing conclusion allowing focus on growth.

See what Kiri Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any immediate or planned fundraising through debt or equity in the provided transcript.
The promoters are focused on increasing their stake using arranged funds or assets, not specifically through fresh equity issuance.
Management plans to use the significant funds expected from the DyStar sale (approx. Rs. 603.8 million) mostly for growth projects, new exciting sectors, and shareholder benefits.
No mention of new debt is made; rather, emphasis is on utilizing existing resources and cash inflows.
The company aims to invest in new projects with high IRR (minimum 25%, target over 30%) primarily funded from internal accruals or proceeds from DyStar.
Management is working on future growth plans but will announce new projects only when crystallized; no immediate capital raising is indicated.

Order book

The transcript provided on page 24 (last page) and previous pages does not contain specific details about the current or expected order book or pending orders of Kiri Industries Limited. The discussions largely focus on: - Litigation issues related to DyStar and court proceedings. - Financial performance including EBITDA and cash flow. - Plans for future projects and diversification. - Sale process timeline for DyStar and expected proceeds. - Efforts to improve efficiencies and product mix. No direct data or figures on the current order book or pending orders were mentioned during the Q&A or management comments. The focus is more on operational restructuring, legal updates, and future growth strategies rather than specific order book details. If you need detailed order book info, it might be contained in earlier parts of the report or separate company disclosures not covered here.

See what Kiri Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

No significant CAPEX needed to improve existing business; focus is on internal improvements within current investments (Page 23).
Efforts ongoing to reduce power costs, improve efficiencies, restart certain buildings with new production, and explore new products using existing facilities (Page 23).
Looking at future projects related to renewable energy, green hydrogen, electric vehicles, and petrochemical derivatives, but nothing has been finalized yet due to market dynamics (Page 23).
Management targets new projects with minimum IRR of 25%, ideally aiming for over 30% IRR (Page 6).
Majority of funds from DyStar sale will be used for future growth and projects to take Kiri to new levels (Page 6).
Projects aligned with India's growth sectors, import replacements, and Atmanirbhar policies are being considered, with announcements expected once funds visibility improves (Page 10).

Track Kiri Industries Ltd — get its next earnings analysis in your feed

How does Kiri Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisKiri Industries Ltd

Rev 4Mar 3

See where Kiri Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Kiri Industries Ltd rank in Chemicals & Petrochemicals?

Compare Kiri Industries Ltd against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Kiri Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →